Skip to content
P&G Hygiene and Health Care logo

P&G Hygiene and Health Care

Procter & Gamble Hygiene and Health Care Ltd

PGHH NSE
₹6,959.00 −97.50 (−1.38%)
P/E
28.57
View as Markdown
MCP
Close 4 Nov 2026 ₹6,959.00 −6,203.00 −47.1% 1Y
Start ₹13,162.00

Key Fundamentals

SmallcapPersonal ProductsFMCG

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
157.00%
Debt to Equity
0.00
EPS (TTM)
₹243.59
Book Value
₹232.12
Market Cap
—
P/E (TTM)
28.57
P/B
29.98
ROE
115.00%
Dividend Yield
3.61%
EBITDA
₹1,214 Cr
52W High
₹13,401.00
52W Low
₹6,579.00
Day Range
₹6,915.00 – ₹7,082.50
Volume
44,443

Peer Comparison

Fast Moving Consumer Goods › Consumer Goods › Personal Care

P&G Hygiene and Health Care peer comparison
Godrej Consumer Products
₹849.0045.38₹86,648 Cr6.891.82%16.10%18.80%₹15,949 Cr₹1,914 Cr
Dabur India
₹395.0035.52₹69,681 Cr6.142.16%17.00%20.30%₹13,552 Cr₹1,947 Cr
Colgate Palmolive
₹1,660.7033.17₹45,422 Cr27.921.47%82.70%108.00%₹6,391 Cr₹1,362 Cr
Cupid
₹336.50329.90₹44,683 Cr100.451.48%27.60%33.90%₹484 Cr₹137 Cr
Gillette
₹7,527.0036.71₹23,745 Cr25.923.32%66.50%90.70%₹3,176 Cr₹668 Cr
P&G Hygiene and Health Care (this company)
₹6,959.0028.57₹22,555 Cr29.983.61%115.00%157.00%₹4,245 Cr₹790 Cr
Emami
₹381.3522.24₹16,773 Cr5.692.62%26.20%28.10%₹3,915 Cr₹749 Cr
Median 7 companies₹849.0035.52₹44,683 Cr25.922.16%27.60%33.90%₹4,245 Cr₹790 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

52 Average

Data confidence 100/100

Category scores

Quality
92
Strong
Returns, margins, earnings quality 22% weight
Valuation
41
Weak
Cheap vs sector & own history 24% weight
Growth
30
Poor
Sales & profit trajectory 9% weight
Financial Health
91
Strong
Solvency, leverage, coverage 9% weight
Momentum
15
Poor
Trend strength, vol-adjusted 12% weight
Ownership
38
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

5
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is providing a good dividend yield of 3.32%.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 89.3%
  • Company has been maintaining a healthy dividend payout of 91.5%

Weaknesses

2
  • Stock is trading at 30.0 times its book value
  • The company has delivered a poor sales growth of 7.40% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish865
OscillatorsBullish162
Moving AveragesStrong Bearish703

Key readings

RSI (14)
46.48
Neutral
MACD (12,26,9)
−91.58
Bullish
SMA (50)
7,271.39
Bearish
SMA (200)
9,284.71
Bearish

As of

Analyst Rating

Based on 3 analysts
BUY67%

2 of 3 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
2
67%
HOLD
1
33%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+27.15%
TTM−1.58%

Net profit

Net profit growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+34.38%
TTM−4.70%

Operating cash flow

Operating cash flow growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+54.52%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YIrregular period
5YIrregular period
3YIrregular period
1Y+1.48 pp
TTM−1.04 pp

Revenue by year

Revenue by year, ₹ crore
Jun 2017₹2,320 Cr
Jun 2018₹2,455 Cr
Jun 2019₹2,947 Cr
Jun 2020₹3,002 Cr
Jun 2021₹3,574 Cr
Jun 2022₹3,901 Cr
Jun 2023₹3,918 Cr
Jun 2024₹4,206 Cr
Mar 2025₹3,374 Cr
Mar 2026₹4,290 Cr

Net profit by year

Net profit by year, ₹ crore
Jun 2017₹433 Cr
Jun 2018₹375 Cr
Jun 2019₹419 Cr
Jun 2020₹433 Cr
Jun 2021₹652 Cr
Jun 2022₹576 Cr
Jun 2023₹678 Cr
Jun 2024₹675 Cr
Mar 2025₹637 Cr
Mar 2026₹856 Cr

Analyst Forecasts

Forecast For
Sep 26 consensus · EBITDA
₹316 Cr +76.0% vs Jun 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 29 Oct 2026
AI opinion · based on fundamentals
Risk high

As of 2026-10-29, Procter & Gamble Hygiene and Health Care Ltd trades at ₹6,923.5 with a market cap of ₹22,474 Cr, a P/E (TTM) of 28.42x, and an exceptional ROE of 113.67%. The stock has declined roughly 49% from its 52-week high of ₹13,496 and currently offers a dividend yield of 3.68%, while revenue growth has been muted at a TTM rate of -2%.

Bull Case 8
  • Virtually zero leverage with a debt-to-equity ratio of 0, giving the company significant financial flexibility and resilience through economic cycles.
  • Exceptional return on equity of 113.67% (last year 115%, 3-year average 89%, 5-year average 83%) indicating highly efficient capital allocation and an asset-light, high-margin business model.
  • ROCE of 135.44% is among the highest in the Indian consumer goods space, reflecting strong operating profitability on deployed capital.
  • Attractive dividend yield of 3.68% as of 2026-10-29, supported by a healthy payout ratio of 91.5%, providing meaningful income even if capital appreciation is subdued.
  • Compounded profit growth of 14% over both 3-year and 5-year periods demonstrates consistent earnings expansion despite modest topline growth.
  • Backed by the global Procter & Gamble parentage, providing access to world-class R&D, brand equity, and supply-chain capabilities in categories like feminine hygiene and healthcare.
  • At a P/E of 28.42x, the stock trades well below its historical premium multiples, with the 49% drawdown from the 52-week high of ₹13,496 compressing valuations relative to its own track record.
  • 10-year compounded profit CAGR of 9% shows the company has steadily grown earnings over a long horizon despite operating in relatively niche FMCG categories.
Bear Case 7
  • Stock price CAGR of -48% over 1 year, -25% over 3 years, and -13% over 5 years signals sustained and severe capital destruction for shareholders across multiple time horizons.
  • TTM sales growth of -2% and a modest 5-year compounded sales CAGR of just 7% indicate limited topline momentum in a market where peers are growing faster.
  • TTM profit decline of -5% shows that even the earnings trajectory, which was the key strength, has turned negative in the most recent period.
  • The 10-year stock CAGR of 0% means the stock has generated zero capital appreciation over a decade, significantly underperforming broader indices and fixed-income alternatives.
  • Narrow product portfolio concentrated in feminine hygiene (Whisper) and healthcare (Vicks), limiting addressable market size compared to diversified FMCG peers.
  • The 91.5% dividend payout ratio, while attractive for income, leaves very little retained earnings for reinvestment, potentially constraining future organic growth and new category expansion.
  • Market cap of ₹22,474 Cr is relatively small for a consumer staples franchise, which can result in lower institutional interest and reduced liquidity compared to larger-cap FMCG names.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

12d ago

TL;DR: Limited news flow for PGHH this period, with the only development being the company quashing delisting and winding-up rumours on Sep 23. While the denial is reassuring, the mere emergence of such rumours warrants monitoring for any shifts in the parent's India strategy. Outlook remains stable in the absence of material fundamental updates.

Neutral 1
  • Denies delisting and winding-up rumours Sep 23

    P&G Hygiene and Health Care on Sep 23 denied circulating rumours of a potential delisting or winding up of operations, calling them baseless. The company reaffirmed its commitment to transparency with stakeholders.

Quarterly Results

₹ Cr
PGHH quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
853
1,138
1,133
1,002
932
1,135
1,248
992
937
1,150
1,262
941
891
Expenses
638
853
824
745
813
845
877
782
671
865
860
723
721
Operating Profit
215
285
310
257
118
290
371
210
266
285
402
218
170
OPM %
25%
25%
27%
26%
13%
26%
30%
21%
28%
25%
32%
23%
19%
Other Income
10
16
16
14
7
8
10
19
8
10
12
12
9
Interest
3
2
3
22
0
2
7
6
0
4
3
3
0
Depreciation
15
14
14
15
13
12
10
10
9
9
10
10
10
PBT
207
284
309
234
112
285
364
213
265
282
402
218
170
Tax %
27%
26%
26%
34%
28%
26%
26%
27%
27%
26%
25%
30%
26%
Net Profit
151
211
229
154
81
212
269
156
192
210
301
153
126
EPS (₹)
46.59
64.91
70.52
47.56
24.97
65.28
82.74
48.09
59.17
64.65
92.87
47.17
38.9

Profit & Loss

₹ Cr
PGHH profit and loss, annual, ₹ crore
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026TTM
Sales
2,334
2,275
2,320
2,455
2,947
3,002
3,574
3,901
3,918
4,206
3,374
4,290
4,245
Expenses
1,838
1,667
1,646
1,834
2,329
2,396
2,688
3,069
3,048
3,230
2,503
3,119
3,170
Operating Profit
495
608
675
622
618
606
886
832
869
976
871
1,171
1,075
OPM %
21%
27%
29%
25%
21%
20%
25%
21%
22%
23%
26%
27%
25%
Other Income
64
85
67
18
45
42
38
23
40
47
37
42
44
Interest
6
6
10
5
5
6
6
11
11
27
14
9
10
Depreciation
53
52
60
52
50
48
48
53
58
56
32
37
38
PBT
501
636
672
582
607
594
870
790
839
939
862
1,167
1,072
Tax %
31%
34%
36%
36%
31%
27%
25%
27%
19%
28%
26%
27%
—
Net Profit
346
422
433
375
419
433
652
576
678
675
637
856
791
EPS (₹)
107
130
133
115
129
133
201
177
209
208
196
264
244
Div. Payout %
28%
28%
292%
35%
68%
79%
157%
90%
89%
123%
89%
97%
—

Balance Sheet

₹ Cr
PGHH balance sheet, annual, ₹ crore
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Equity Capital
32
32
32
32
32
32
32
32
32
32
32
32
Reserves
1,196
1,619
494
773
877
1,125
682
705
914
742
705
721
Borrowings
0
0
0
0
0
0
3
5
4
3
2
1
Other Liabilities
719
515
634
620
708
671
915
940
1,187
1,081
1,015
1,049
Total Liabilities
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
Fixed Assets
309
317
286
250
234
206
184
164
170
139
131
163
CWIP
39
35
41
21
15
22
38
44
23
28
41
21
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1,600
1,814
834
1,154
1,368
1,600
1,411
1,475
1,945
1,692
1,583
1,619
Total Assets
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804

Cash Flow

₹ Cr
PGHH cash flow, annual, ₹ crore
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Operating
426
352
445
415
413
474
863
573
826
470
598
924
Investing
28
221
149
−19
34
75
7
−27
−10
1
−34
11
Financing
−105
−122
−1,559
−106
−314
−190
−1,106
−569
−477
−861
−671
−845
Net Cash Flow
349
452
−964
290
134
358
−236
−23
339
−390
−107
91
Free Cash Flow
348
300
401
377
410
423
832
523
781
427
544
893
CFO/EBITDA
127
91
103
111
105
102
126
99
121
79
96
105

Ratios

PGHH financial ratios, annual
Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Debtor Days
18
24
21
22
22
20
15
18
20
21
33
21
Inventory Days
47
53
71
48
60
68
78
55
48
51
64
51
Days Payable
148
134
145
156
162
175
237
183
213
193
235
197
Cash Conversion Cycle
−83
−57
−53
−87
−79
−87
−144
−110
−145
−121
−138
−126
Working Capital Days
4
8
−15
−23
−12
−21
−39
−34
−53
−32
−30
−31
ROCE %
46%
45%
64%
89%
73%
58%
94%
110%
101%
112%
104%
157%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view P&G Hygiene and Health Care insights

63 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 70.64%
  • DIIs 15.04%
  • Public 10.83%
  • Others 2.88%
  • FIIs 0.62%

No promoter shares pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about P&G Hygiene and Health Care

What does Procter & Gamble Hygiene and Health Care Ltd do?
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses.
Where is Procter & Gamble Hygiene and Health Care Ltd (PGHH) listed?
Procter & Gamble Hygiene and Health Care Ltd trades as PGHH on the NSE and under code 500459 on the BSE.
Which sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the PE ratio of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd trades at a PE ratio of 28.57 as of 4 Nov 2026, on earnings per share of ₹243.59, against a book value of ₹232.12 per share.
What is the 52-week high and low of Procter & Gamble Hygiene and Health Care Ltd?
Over the last 52 weeks Procter & Gamble Hygiene and Health Care Ltd has traded between ₹6,579 and ₹13,401 as of 4 Nov 2026.
Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?
Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 3.61%.
What is the Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd reported a return on equity of 115.00%. Its debt-to-equity ratio is 0.00.

Company Information

Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.

Website pg.com/en_IN
Listed 7 Jul 2004
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PGHH.md for Procter & Gamble Hygiene and Health Care Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Personal Care stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month